Combination therapies in rheumatoid arthritis-choose your partner carefully

被引：0
作者：
Rubbert-Roth, Andrea [1 ]
机构：
[1] Cantonal Hosp St Gallen, Div Rheumatol, CH-9007 St Gallen, Switzerland
来源：
LANCET RHEUMATOLOGY | 2022年 / 4卷 / 06期
关键词：
D O I：
10.1016/S2665-9913(22)00108-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E376 / E377
页数：2
相关论文
共 10 条
  • [1] Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden
    Einarsson, Jon T.
    Willim, Minna
    Saxne, Tore
    Geborek, Pierre
    Kapetanovic, Meliha C.
    [J]. RHEUMATOLOGY, 2020, 59 (01) : 205 - 212
  • [2] Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial
    Fleischmann, Roy
    Friedman, Alan
    Drescher, Edit
    Singhal, Atul
    Cortes-Maisonet, Gregorio
    Doan, Thao
    Lu, Wenjing
    Wang, Zailong
    Nader, Ahmed
    Housley, William
    Cohen, Stanley
    Taylor, Peter C.
    Blanco, Ricardo
    [J]. LANCET RHEUMATOLOGY, 2022, 4 (06) : E395 - E406
  • [3] Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate
    Genovese, MC
    Cohen, S
    Moreland, L
    Lium, D
    Robbins, S
    Newmark, R
    Bekker, P
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (05): : 1412 - 1419
  • [4] Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study
    Glatt, Sophie
    Taylor, Peter C.
    McInnes, Iain B.
    Schett, Georg
    Landewe, Robert
    Baeten, Dominique
    Ionescu, Lucian
    Strimenopoulou, Foteini
    Watling, Mark I. L.
    Shaw, Stevan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (08) : 1033 - 1040
  • [5] Goess C, 2019, MOD RHEUMATOL, V29, P510, DOI 10.1080/14397595.2018.1484269
  • [6] Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
    Rubbert-Roth, Andrea
    Enejosa, Jeffrey
    Pangan, Aileen L.
    Haraoui, Boulos
    Rischmueller, Maureen
    Khan, Nasser
    Zhang, Ying
    Martin, Naomi
    Xavier, Ricardo M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (16) : 1511 - 1521
  • [7] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
    Smolen, Josef S.
    Landewe, Robert
    Breedveld, Ferdinand C.
    Dougados, Maxime
    Emery, Paul
    Gaujoux-Viala, Cecile
    Gorter, Simone
    Knevel, Rachel
    Nam, Jackie
    Schoels, Monika
    Aletaha, Daniel
    Buch, Maya
    Gossec, Laure
    Huizinga, Tom
    Bijlsma, Johannes W. J. W.
    Burmester, Gerd
    Combe, Bernard
    Cutolo, Maurizio
    Gabay, Cem
    Gomez-Reino, Juan
    Kouloumas, Marios
    Kvien, Tore K.
    Martin-Mola, Emilio
    McInnes, Iain
    Pavelka, Karel
    van Riel, Piet
    Scholte, Marieke
    Scott, David L.
    Sokka, Tuulikki
    Valesini, Guido
    van Vollenhoven, Ronald
    Winthrop, Kevin L.
    Wong, John
    Zink, Angela
    van der Heijde, Desiree
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) : 964 - 975
  • [8] The Development of BTK Inhibitors: A Five-Year Update
    Tasso, Bruno
    Spallarossa, Andrea
    Russo, Eleonora
    Brullo, Chiara
    [J]. MOLECULES, 2021, 26 (23):
  • [9] Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial
    Weinblatt, Michael
    Schiff, Michael
    Goldman, Allan
    Kremer, Joel
    Luggen, Michael
    Li, Tracy
    Chen, Dalei
    Becker, Jean-Claude
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) : 228 - 234
  • [10] Ytterberg SR, 2022, NEW ENGL J MED, V386, P316, DOI [10.1056/NEJMoa2109927, 10.1056/NEJMc2202778]
1